A/H1N1 Immunogenicity and Safety in Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of the study is to obtain immunogenicity and safety data at different dose levels of an investigational H1N1 pandemic influenza vaccine in healthy adults 18 years of age and older.
Epistemonikos ID: a994d38da254e9ba9607ec7ef43b6452e01ba8dc
First added on: May 05, 2024